Reduzzi, Carolina
Carolina Reduzzi is a Research Associate at Weill Cornell Medicine. She obtained a degree with laude in Biology Applied to Biomedical Research in 2014 at the University of Milan. She has been working on liquid biopsy for the last decade, first at the National Cancer Institute of Milan (Fondazione IRCCS Istituto Nazionale dei Tumori), where she obtained her PhD in 2020, and subsequently at the Northwestern University of Chicago, where she conducted her postdoctoral research on circulating tumor cells in breast cancer. Since 2022 she is the Director of Dr. Cristofanilli's laboratory at Weill Cornell Medicine. She is a member of the Young Committee of the International Society of Liquid Biopsy, reviewer for different journals including Cell Reports, Scientific Reports, Cancers and BMC Cancer, and grant reviewer for the Italian Health Ministry and the Fondation Toulouse Cancer Santé.
Gerratana, Lorenzo
Lorenzo Gerratana is a Physician scientist at the IRCCS CRO Aviano National cancer Institute and a Research fellow at the Department of Medicine at the University of Udine. After graduating as MD, he focused on DNA repair in vitro models in Triple Negative Breast Cancer, clinical methodology and endpoint analysis. As a medical oncology fellow at the University of Udine and visiting scholar at the Northwestern University of Chicago he focused his research on liquid biopsy and big data, with the aim of transferring promising tissue and liquid biopsy-based biomarkers and treatment strategies from the bench to the bedside, with a pragmatic imprinting towards clinical utility and transferability. He currently serves as Attending Physician at the IRCCS CRO Aviano National Cancer Institute as part of the Breast Unit and the Precision Medicine Multidisciplinary Team.
